NCT04702087

Omega 3, Leucine, Probiotic Lactobacillus Paracasei PS23 on Muscle Mass in Sarcopenic Subjects

Randomized, Placebo-controlled Clinical Study to Evaluate the Effect of 2 Months of Nutritional Support Based on Omega 3, Leucine, Probiotic Lactobacillus Paracasei PS23 (OLEP Study) on Muscle Mass in Sarcopenic Subjects

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 54 (estimated)
• Sponsor: Azienda di Servizi alla Persona di Pavia · Academic / Other
• Sex: All
• Age: 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to evaluate the effect of supplementation with a nutritional blend based on Omega 3 fatty acids, the probiotic leucine Lactobacillus paracasei PS23 (OLEP), on muscle mass recovery in sarcopenic patients.

Conditions

• Sarcopenia
• Elderly
• Omega 3

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	OLEP	omega 3 (500 mg), leucine (2,5 g), probiotic Lactobacillus paracasei PS23
COMBINATION_PRODUCT	Placebo	Isocaloric formula

Timeline

• Start date: 2021-01-22
• Primary completion: 2021-01-30
• Completion: 2022-12-01
• First posted: 2021-01-08
• Last updated: 2021-10-05

Locations

1 site across 1 country: Italy